Pathologic Response After Weekly Paclitaxel versus Docetaxel in Operable Breast Cancer.

Xenia Elena BacinschiRodica Maricela AnghelPaula Iuliana TomaInga SaftaAlis IlieSilvia Mihaela Ilie

Published in: Cancer management and research (2020)

Our study showed an improved efficacy of taxane's weekly administration, probably due to a better tolerance and a lower rate of dose-impairing toxicities.

Keyphrases

locally advanced
neoadjuvant chemotherapy
radiation therapy
young adults
lymph node
metastatic breast cancer